Viramune 400 mg prolonged-release tablets

Licence status
Authorised: 16/09/2011
Active substances
Nevirapine
Dosage Form
Prolonged-release tablet
Licence number
EU/1/97/055/007-009
Licence holder
Boehringer Ingelheim International GmbH

Product documents

Licence information

ATC code
J05AG Non-nucleoside reverse transcriptase inhibitors, J05AG01 nevirapine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
16/09/2011